Capsugel broadens commercial availability of MAST system

Modular Automated Sampling Technology allows direct aseptic transfer of bioreactor samples to analytical devices

MAST is the latest innovation developed by Capsugel to address biopharmaceutical product development and processing challenges

Capsugel, a global innovator in dosage forms and solutions, has announced the broad commercial availability of its Modular Automated Sampling Technology (MAST) system, which directly transfers samples from bioreactors to analytical devices while maintaining process sterility.

This first-of-its-kind technology allows aseptic collection of accurate, representative samples that generate detailed process information in real-time.

MAST represents the latest innovation developed by Capsugel to address biopharmaceutical product development and processing challenges.

“Capsugel’s MAST system meets a pressing industry need for improved bioprocess guidance,” said David Lyon, Head of Biotherapeutics, Capsugel.

“Real-time product-quality-attribute control is now being used to maximise protein manufacture in bioreactors.

“This game-changing advancement gives our customers confidence that their samples are representative of their entire batch and that sterility is maintained.”

MAST provides a modular system that is readily scalable and suitable for use throughout the product development process.

The system instantaneously provides a wide range of information at the molecular level for media, cells and bioreactor products, allowing for rapid response to maintain optimum bioreactor conditions and maximize yields.

The commercial availability of the technology is the culmination of a focused five-year programme conducted by Capsugel’s Bend, Oregon facility, in collaboration with several of the world’s largest biopharmaceutical companies.

The company has also developed alliances with numerous leading analytical equipment suppliers to facilitate process analytical technology (PAT) integration into bioprocessing through MAST.

“Our rigorous testing and collaborative work with equipment manufacturers and end users has demonstrated the MAST platform’s reliability, accuracy and value,” said Clint Pepper, head of the MAST programme at Capsugel.

He added that the systems integrated design has “enabled increased sampling frequency and reproducibility, as well as improved data reliability when compared with manual sampling”.

The system can be readily expanded with additional sampling modules as required. Its software allows for configurable, flexible and user-friendly operation, with special modules for sample scheduling, sample navigation and analytical data management.

Companies